Position in NTRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$286,108
-$118,892 QoQ
Shares Held
1,054
-58.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#614
of 844 holders
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026OXFORD ASSET MANAGEMENT LLP holds $2,686,479 across 7 Diagnostics & Research names. NTRA ranks #5 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
5,013 | $665,876 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
1,074 | $565,396 | |
| 3 | DHR |
Danaher Corp /De/
|
2,351 | $447,818 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
1,610 | $311,084 | |
| 5 | NTRA |
Natera, Inc.
This page
|
1,054 | $286,108 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
410 | $205,557 | |
| 7 | GH |
Guardant Health, Inc.
|
1,364 | $204,640 |
All Filings in NTRA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $286,108 | 1,054 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $405,000 | 2,516 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||